Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.100
-0.040 (-3.51%)
Mar 26, 2026, 11:49 AM EDT - Market open

RANI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1074686149322-
Market Cap Growth
120.61%-47.02%-42.08%-53.69%--
Enterprise Value
120.7132.9174.96117.12278.990
Last Close Price
1.101.373.325.9016.35-
PE Ratio
--1.30-2.50-4.61-38.02-
PS Ratio
89.4144.55--118.62-
PB Ratio
-22.996.724.056.80-
P/TBV Ratio
-5.2219.586.583.816.74-
P/FCF Ratio
--1.28-1.65-3.10-9.84-
P/OCF Ratio
--1.29-1.69-3.21-10.00-
EV/Sales Ratio
100.5932.01--102.68-
EV/EBITDA Ratio
--0.63-1.15-1.86-5.46-
EV/EBIT Ratio
--0.62-1.13-1.85-5.41-
EV/FCF Ratio
--0.92-1.43-2.43-8.52-
Debt / Equity Ratio
-0.253.790.960.390-0.02
Debt / EBITDA Ratio
-0.39-0.57-0.46-0.48--0.24
Debt / FCF Ratio
--0.83-0.57-0.63--0.23
Net Debt / Equity Ratio
-1.711.04-1.43-1.85-2.480.61
Net Debt / EBITDA Ratio
-0.30-0.040.281.092.304.34
Net Debt / FCF Ratio
--0.060.351.423.594.29
Asset Turnover
0.050.02000.030.01
Quick Ratio
0.221.416.0820.4544.4914.09
Current Ratio
0.261.506.3620.9645.3014.12
Return on Equity (ROE)
1122.59%-391.10%-136.52%-64.78%-1290.42%35.36%
Return on Assets (ROA)
-191.28%-112.77%-79.66%-54.58%-50.64%-32.23%
Return on Invested Capital (ROIC)
-1278.09%-848.54%-1037.74%-1286.92%-1116.12%-398.20%
Return on Capital Employed (ROCE)
-1156.19%-159.93%-86.33%-56.46%-52.74%-35.34%
Earnings Yield
-26.39%-76.64%-40.06%-21.69%-2.63%-
FCF Yield
-25.89%-78.09%-60.70%-32.25%-10.16%-
Buyback Yield / Dilution
--40.58%-0.27%0.21%-22.86%-
Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q